Acura Pharmaceuticals Inc. (NASDAQ:ACUR)
CAPS Rating:
A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.
A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
FDA approval is looming in Jan to March 2010 when it does acura will hit 12 to 15 or be bought or both king will scoop it up